Now showing items 1-2 of 2

    • Haemochromatosis patients' research priorities: Towards an improved quality of life 

      Romero-Cortadellas, Lídia; Venturi, Veronica; Martín-Sánchez, Juan Carlos; Toska, Ketil; Prince, Dianne; Butzeck, Barbara; Porto, Graça; Thorm Milman, Nils; HI/EFAPH Survey Committee; Sánchez, Mayka (Health Expectations, 2023)
      Background: Chronic diseases are associated with a range of functional and psychosocial consequences that can adversely affect patients' quality of life (QoL). Haemochromatosis (HC) is a genetically ...
    • Therapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype 

      Adams, Paul; Altes, Albert; Brissot, Pierre; Butzeck, Barbara; Cabantchik, Ioav; Cançado, Rodolfo; Distante, Sonia; Evans, Patricia; Evans, Robert; Ganz, Tomas; Girelli, Domenico; Hultcrantz, Rolf; McLaren, Gordon; Marris, Ben; Milman, Nils; Nemeth, Elizabeta; Nielsen, Peter; Pineau, Brigitte; Piperno, Alberto; Porto, Graça; Prince, Dianne; Ryan, John; Sanchez, Mayka; Santos, Paulo; Swinkels, Dorine; Teixeira, Emerência; Toska, Ketil; Vanclooster, Annick; White, Desley; Contributors and Hemochromatosis International Taskforce (Hepatology International, 2018)
      Although guidelines are available for hereditary hemochromatosis, a high percentage of the recommendations within them are not shared between the different guidelines. Our main aim is to provide an ...